Skip to main content

Table 6 Clinical characteristics of BC patients with high cumulative genetic risk score (≥4 risk alleles)

From: Genetic variants in ATM, H2AFX and MRE11 genes and susceptibility to breast cancer in the polish population

Characteristics

BC patients

with ≥4 risk alleles

with < 4 risk alleles

Mean age at diagnosis (yrs.)

 

53

54

Histological subtype of breast cancer No. (%)

 Ductale

55 (77.5)

136 (55.7)

 Lobulare

6 (8.5)

29 (11.9)

 Tubular carcinoma

2 (2.8)

13 (5.3)

 Ductalolobular

11 (4.5)

 Tubuloductale

6 (8.5)

 Solidum

1 (1.4)

1(0.4)

 Mucinosum

2 (0.8)

 Metaplasticum

1 (1.4)

1(0.4)

 Unknown

51(20.9)

Tumor grade No. (%)

 G1

31 (12.7)

 G2

33 (46.5)

58 (23.8)

 G3

13 (18.3)

42 (17.2)

 Gx

25 (35.2)

50 (20.5)

 Unknown grade

63 (25.8)

Family history of cancers No. (%)

 Positive

18 (25.4)

83 (34)

 Negative

53 (74.6)

118 (48.4)

 Unknown status

43 (17.6)

T stage at diagnosis No. (%)

 T1

16 (22.5)

27 (11.1)

 T2

36 (50.7)

107 (43.9)

 T3

10 (14.1)

27 (11.1)

 T4

9 (12.7)

18 (7.4)

 Tx

7 (2.9)

 Unknown T stage

58 (23.6)

ERstatus No. (%)

 ER positive

25 (35.2)

127 (52)

 ER negative

42 (59.2)

60 (24.6)

 ER unknown

4 (5.6)

57 (23.4)

PgR status No. (%)

 PgR positive

30 (42.3)

124 (50.8)

 PgR negative

39 (54.9)

62 (25.4)

 PgR unknown

2 (2.8)

58 (23.8)

  1. BC = breast cancer patients, ER = estrogen receptor, PgR = progesterone receptors